Primary Site >> Pancreatic Cancer

Gene >> NEU1

Journal: Cell Signal. 2013 Dec;25(12):2587-603.
Title: A novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancer.
Author: Gilmour, Alanna M|Abdulkhalek, Samar|Cheng, Timothy S W|Alghamdi, Farah|Jayanth, Preethi|O'Shea, Leah K|Geen, Olivia|Arvizu, Luis A|Szewczuk, Myron R
PMID: 23993964
Journal: Onco Targets Ther. 2014 Jan 16;7:117-34.
Title: Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu(R)) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance.
Author: O'Shea, Leah K|Abdulkhalek, Samar|Allison, Stephanie|Neufeld, Ronald J|Szewczuk, Myron R
PMID: 24470763
Journal: PLoS One. 2014 Sep 3;9(9):e106343.
Title: A miRNA signature of chemoresistant mesenchymal phenotype identifies novel molecular targets associated with advanced pancreatic cancer.
Author: Bera, Alakesh|VenkataSubbaRao, Kolaparthi|Manoharan, Muthu Saravanan|Hill, Ping|Freeman, James W
PMID: 25184537
Journal: Biomater Sci. 2016 Mar;4(3):511-21.
Title: Oseltamivir-conjugated polymeric micelles prepared by RAFT living radical polymerization as a new active tumor targeting drug delivery platform.
Author: Kapishon, Vitaliy|Allison, Stephanie|Whitney, Ralph A|Cunningham, Michael F|Szewczuk, Myron R|Neufeld, Ronald J
PMID: 26788555
Journal: Drug Des Devel Ther. 2017 Jul 31;11:2239-2250.
Title: Combinatorial and sequential delivery of gemcitabine and oseltamivir phosphate from implantable poly(d,l-lactic-co-glycolic acid) cylinders disables human pancreatic cancer cell survival.
Author: Allison Logan, Stephanie|Brissenden, Amanda J|Szewczuk, Myron R|Neufeld, Ronald J
PMID: 28814832
Journal: Oncotarget. 2018 Jan 29;9(16):12754-12768.
Title: Oseltamivir phosphate released from injectable Pickering emulsions over an extended term disables human pancreatic cancer cell survival.
Author: Wood, Kurt|Szewczuk, Myron R|Rousseau, Derick|Neufeld, Ronald J
PMID: 29560107